Foxhollow Technologies, a manufacturer of SilverHawk, a minimally invasive catheter system for the treatment of peripheral artery disease, announced on Wednesday the terms for its upcoming IPO. The company plans to offer 4.5 mm shares between a pricing range of $12 to $14 per share, with a resulting market cap of $287 million. JP Morgan is lead managing the offering, and a pricing date has not yet been determined.
